Trademark: 87463877
Word
RETHINKDEPRESSION
Status Date
Tuesday, November 13, 2018
Registration Number
5604219
Registration Date
Tuesday, November 13, 2018
Filing Date
Thursday, May 25, 2017
Published for Opposition
Tuesday, August 28, 2018
41 Education services, namely, arranging and conducting seminars, conferences, symposiums, workshops and courses in the field of medical research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational and training services in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing the aforementioned services electronically, on-line, via cable or Internet or other electronic media; arranging and conducting expert forums, including on-line in the form of seminars, conferences, symposiums, workshops and courses in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing on-line training programs in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders; providing on-line publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders
5 Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; medical preparations, substances, reagents and diagnostic agents for medical purposes
44 Medical and therapeutic services relating to the treatment and prevention of brain and central nervous system diseases and disorders; healthcare services, namely, clinical healthcare; medical, clinical, therapeutic clinical services in the field of brain and central nervous system diseases and disorders; healthcare information services; medical services in the field of psychiatry and psychology and medical treatment of central nervous system related diseases and disorders; medical advice related to the treatment of central nervous system diseases and disorders; healthcare and medical services related to the treatment and prevention of central nervous system and brain diseases and disorders; providing medical and medicinal information in the field of diagnostics, medicine and pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system; providing on-line medical information, namely, data and analyses designed to provide patients and clients with customized information regarding diagnosis and treatment
42 Scientific and technological services, namely, research and design in the field of pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system; medical and scientific research, namely, conducting clinical trials for others; clinical studies tests and trials; industrial analysis and research in the field of research and development relating to the treatment and prevention of diseases and disorders of the central nervous system; pharmaceutical research and development services; medical research; providing information in the field of research and development related to the treatment and prevention of central nervous system diseases and disorders
The mark consists of the letters "RETHINKDEPRESSION" in red with a red circle and a red thought cloud over the letter "I", The color white is not claimed as a feature of the mark and represents background.
RETHINK DEPRESSION
The color(s) red is/are claimed as a feature of the mark.
Mar 22, 2024
Teas Change Of Correspondence Received
Mar 22, 2024
Teas Change Of Domestic Representatives Address
Mar 22, 2024
Teas Withdrawal As Domestic Representative Received
Mar 22, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 22, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 13, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Nov 13, 2018
Registered-Principal Register
Aug 28, 2018
Official Gazette Publication Confirmation E-Mailed
Aug 28, 2018
Published For Opposition
Aug 8, 2018
Notification Of Notice Of Publication E-Mailed
Jul 23, 2018
Electronic Record Review Complete
Jul 20, 2018
On Hold - Electronic Record Review Required
Jul 16, 2018
Approved For Pub - Principal Register
Jul 16, 2018
Examiner's Amendment Entered
Jul 16, 2018
Assigned To Lie
Jul 16, 2018
Notification Of Examiners Amendment E-Mailed
Jul 16, 2018
Examiners Amendment E-Mailed
Jul 16, 2018
Examiners Amendment -Written
Jan 24, 2018
Notification Of Non-Final Action E-Mailed
Jan 24, 2018
Non-Final Action E-Mailed
Jan 24, 2018
Non-Final Action Written
Jan 3, 2018
Teas/Email Correspondence Entered
Jan 2, 2018
Correspondence Received In Law Office
Jan 2, 2018
Teas Response To Office Action Received
Jul 10, 2017
Notification Of Non-Final Action E-Mailed
Jul 10, 2017
Non-Final Action E-Mailed
Jul 10, 2017
Non-Final Action Written
Jul 3, 2017
Assigned To Examiner
Jun 2, 2017
Notice Of Design Search Code E-Mailed
Jun 1, 2017
New Application Office Supplied Data Entered
May 29, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
